Nuclear Medicine — Medicare Part B billing by state
6 physician groups whose primary specialty is Nuclear Medicine billed $0.02B to Medicare fee-for-service in 2024.
Calendar year 2024 · Medicare fee-for-service Part B
| State | Groups | Services | Beneficiary-episodes | Medicare payments | Standardized payments ↓ | Payments / group | Services / group |
|---|---|---|---|---|---|---|---|
| Virginia | 1 | 29,275 | 5,876 | $7,291,402 | $7,590,792 | $7,291,402 | 29,275 |
| California | 1 | 73,671 | 14,618 | $4,583,824 | $4,687,220 | $4,583,824 | 73,671 |
| Florida | 2 | 161,434 | 17,697 | $2,443,852 | $2,365,098 | $1,221,926 | 80,717 |
| New York | 1 | 7,193 | 6,675 | $964,722 | $898,964 | $964,722 | 7,193 |
| South Carolina | 1 | 3,797 | 1,302 | $56,924 | $63,417 | $56,924 | 3,797 |
| Washington | 1 | 774 | 756 | $22,667 | $22,076 | $22,667 | 774 |
Need this specialty's market in one document?
Notify me at launchEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2024
| Code | Services | Medicare payments ↓ | Largest state markets |
|---|---|---|---|
| 78815 · Nuclear medicine study from skull base to mid-thigh with ct scan | 7,405 | $3,122,656 | VACAFLNYSC |
| Q9983 · Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | 681 | $1,709,561 | VACAFLNYSC |
| A9595 · Piflufolastat f-18, diagnostic, 1 millicurie | 3,283 | $1,602,621 | VACAFLNYSC |
| 78814 · Nuclear medicine study limited area with ct scan | 794 | $1,166,913 | VACAFLNYSC |
| 78431 · Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 475 | $735,373 | VACAFLNYSC |
| A9584 · Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | 343 | $723,014 | VACAFLNYSC |
| A9596 · Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 680 | $553,148 | VACAFLNYSC |
| J9271 · Injection, pembrolizumab, 1 mg | 10,600 | $472,381 | VACAFLNYSC |
| J0897 · Injection, denosumab, 1 mg | 21,060 | $431,513 | VACAFLNYSC |
| 78816 · Nuclear medicine study whole body with ct scan | 1,369 | $408,610 | VACAFLNYSC |
| J1437 · Injection, ferric derisomaltose, 10 mg top by services | 13,600 | $215,560 | VACAFLNYSC |
| 96375 · Injection of additional new drug or substance into vein top by services | 6,978 | $91,030 | VACAFLNYSC |
| 85025 · Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count top by services | 4,839 | $36,721 | VACAFLNYSC |
| Q5125 · Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram top by services | 58,560 | $22,219 | VACAFLNYSC |
| A9577 · Injection, gadobenate dimeglumine (multihance), per ml top by services | 5,218 | $7,473 | VACAFLNYSC |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | 64,684 | $6,679 | VACAFLNYSC |
| J1453 · Injection, fosaprepitant, 1 mg top by services | 8,100 | $906 | VACAFLNYSC |
Every code above is searchable free at full depth. Ranking organizations across several codes at once — one combined market view — is part of a Nevvi subscription.
Notify me at launch